#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14942	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2409	761.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1829	1829	T	908	T,C,A,G	900,3,4,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14942	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2409	761.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1563	1563	C	951	C	951	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25412	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4099	773.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	2005	2005	A	990	A	990	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25412	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4099	773.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2639	2639	C	885	C,G	884,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25412	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4099	773.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2713	2713	A	782	A	782	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25412	23S	2890	2890	99.93	23S.l6.c17.ctg.1	4099	773.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3265	3265	C	942	C,T	939,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	G5V	NONSYN	13	15	GGT	526	528	GTT	129;129;129	G;T,G;T	129;128,1;129	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	E12K	NONSYN	34	36	GAA	547	549	AAA	151;151;150	A;A;A	151;151;150	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	F31L	NONSYN	91	93	TTT	604	606	TTG	184;183;182	T,G;T;G	183,1;183;182	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	637	639	CAA	210;206;205	C,A;A;A	209,1;206;205	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	S75P	NONSYN	223	225	TCC	736	738	CCT	204;204;205	C;C,T;T,C,G	204;203,1;203,1,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	V87A	NONSYN	259	261	GTA	772	774	GCA	175;172;172	G;C;A	175;172;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	V130L	NONSYN	388	390	GTC	901	903	CTC	189;187;188	C,A;T;C	188,1;187;188	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	R135C	NONSYN	403	405	CGC	916	918	TGT	196;194;192	T;G;T,G	196;194;191,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	T137A	NONSYN	409	411	ACG	922	924	GCG	192;197;197	G;C;G	192;197;197	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	E151K	NONSYN	451	453	GAA	964	966	AAG	215;214;214	A;A;G	215;214;214	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	T152N	NONSYN	454	456	ACC	967	969	AAT	213;216;216	A;A;T	213;216;216	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1165	1167	TTG	131;132;133	T;T;G	131;132;133	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1195	1197	AGC	120;120;121	A;G;C	120;120;121	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1264	1266	CTG	94;93;95	C;T;G	94;93;95	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1270	1272	TCC	91;93;93	T;C;C	91;93;93	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1285	1287	GTG	108;111;113	G;T;G	108;111;113	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1676	folP	852	852	93.78	folP.l15.c4.ctg.1	1879	110.7	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1336	1338	GCG	171;170;169	G;C;G	171;170;169	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5338	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4024	165.6	1	SNP	p	S91F	0	.	.	271	273	TCC	911	913	TCC	204;206;210	T;C;C,A	204;206;209,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5338	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4024	165.6	1	SNP	p	D95G	0	.	.	283	285	GAC	923	925	GAC	224;225;224	G;A;C	224;225;224	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5338	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	4024	165.6	1	SNP	p	D95N	0	.	.	283	285	GAC	923	925	GAC	224;225;224	G;A;C	224;225;224	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1922	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1923	124.8	1	SNP	p	G45D	0	.	.	133	135	GGC	809	811	GGC	241;241;238	G;G;C	241;240;238	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1056	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c30.ctg.1	1639	80.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1795	1797	ATC	254;252;252	A,T;T,A;C	252,2;251,1;252	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1948	1950	GCA	240;245;246	G;C;A	240;245;246	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	1	SNP	p	D86N	0	.	.	256	258	GAC	901	903	GAC	233;234;235	G,A;A;C	232,1;234;235	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	1	SNP	p	S87W	0	.	.	259	261	AGT	904	906	AGT	235;232;231	A;G;T	235;232;231	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	1	SNP	p	S87I	0	.	.	259	261	AGT	904	906	AGT	235;232;231	A;G;T	235;232;231	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	1	SNP	p	S87R	0	.	.	259	261	AGT	904	906	AGT	235;232;231	A;G;T	235;232;231	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4822	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3479	173.0	1	SNP	p	S88P	0	.	.	262	264	TCC	907	909	TCC	235;237;240	T,G;C,A;C,G	234,1;235,2;239,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4376	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3240	168.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1886	1888	GGC	237;233;228	G;G;C	237;233;228	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1517	1519	GCA	238;237;237	G,A;C;A,G	237,1;237;236,1	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1520	1522	ATC	237;237;237	A;T,C;C	237;236,1;237	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1532	1534	GTG	240;242;242	G;T,C;G	240;241,1;242	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1532	1534	GTG	240;242;242	G;T,C;G	240;241,1;242	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2036	2038	ACC	234;232;234	A;C;C,A	234;232;233,1	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2090	2092	GCG	232;232;232	G;C,G;G	232;231,1;232	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2090	2092	GCG	232;232;232	G;C,G;G	232;231,1;232	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2213	2215	GGT	265;268;268	G;G,A;T,G	265;266,1;266,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2222	2224	GGC	278;280;278	G,A;G,A;C	276,1;278,1;277	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4136	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2907	177.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2240	2242	CCG	268;268;268	C,G,A;C;G,T	265,1,1;267;266,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5818	ponA	2397	2397	99.96	ponA.l6.c17.ctg.1	3612	201.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1864	1866	CTG	226;231;231	C;T,C,G;G	226;229,1,1;231	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2364	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2509	117.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	732	734	GGC	158;156;155	G;G;C	158;156;155	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2364	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2509	117.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	914	914	C	197	C	197	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	25;26;27	T;T;A	25;26;27	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	69;69;69	C,T;A;T	68,1;69;69	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	69;69;69	A;G;T	69;69;69	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	69;69;69	T;A;C	69;69;69	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	3;3;4	G;C;C	3;3;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	316	porB1a	984	226	90.71	porB1a.l15.c4.ctg.4	396	33.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	4;4;4	G;T;T	4;4;4	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	0	.	p	.	0	T206K	NONSYN	616	618	ACT	1050	1052	AAA	264;265;265	A,T,C;A;A	262,1,1;265;265	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	0	.	p	.	0	.	MULTIPLE	622	623	AA	1057	1059	TCG	262;260;258	T,G;C;G	261,1;260;258	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	0	.	p	.	0	I209fs	FSHIFT	625	625	A	1061	1061	A	258	A	258	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	1	SNP	p	G120K	0	.	.	358	360	GGT	792	794	GGT	261;261;263	G;G;T	260;260;263	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	1	SNP	p	A121D	0	.	.	361	363	GCC	795	797	GCC	261;260;265	G;C;C,A	261;260;264,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3144	porB1b	1035	1035	98.47	porB1b.l15.c17.ctg.1	1648	235.9	1	SNP	p	A121N	0	.	.	361	363	GCC	795	797	GCC	261;260;265	G;C;C,A	261;260;264,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10538	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	5443	241.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1444	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1403	128.0	1	SNP	p	V57M	1	.	.	169	171	ATG	685	687	ATG	259;261;257	A;T;G	259;261;257	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
